**Dear Editor**,

As of February, 2018 a total of 2143 cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) have been reported to the World Health Organization, including 750 deaths in 27 countries.[@bib1] There were 10 reported cases of MERS-CoV in pregnancy.[@bib2], [@bib3], [@bib4], [@bib5], [@bib6], [@bib7] Here, we present two cases form our hospital with MERS-CoV infections during pregnancy.

Case 1 {#sec1}
======

The first patient was a 29-year-old female (gravida 2, para 1) at 6 weeks gestation and with no underlying medical conditions. She was asymptomatic and identified as part of the contact tracing of her mother, a positive MERS-CoV patient. On examination, she was afebrile, breathing normally and Lungs were clear to auscultation. The abdomen was gravid, soft, non-tender, non-distended, and normal bowel sounds. Nasopharyngeal swab testing by RT-PCR for MERS-CoV showed a positive result for ORF (Ct value 32). She had two repeated nasopharyngeal swab testing by RT-PCR for MERS-CoV and these showed probable results (Ct value 36) and the 4th swab was negative by PCR for MERS-CoV. The patient did not deliver during hospitalization and she was discharged on 24th August 2015, and subsequently delivered a healthy infant at term.

Case 2 {#sec2}
======

The second patient was a 39-year-old female (gravida 6, para 5) with history of end stage renal disease (ESRD) and hypertension on hemodialysis. She used to have hemodialysis at Wadi Aldawasir hospital during an active MERS-CoV outbreak there. She presented at 24 weeks of gestation after a contact with a positive MERS-CoV patient. Nasopharyngeal swab testing by RT-PCR was positive for MERS-CoV with E gene (Ct value 34) and OFR (Ct value 34). She was admitted to a regular ward. Subsequently, she had negative RT-PCR for MERS-CoV and she was discharged home.

Respiratory samples (Nasopharyngeal swabs or tracheal aspirates) were tested for MERS-CoV using real-time reverse-transcription polymerase chain reaction (RT-PCR) as described previously.

The clinical presentation of MERS-CoV is variable and ranges from a mild disease or asymptomatic presentation to a more severe and fatal cases. There are sparse data on the effect and the likelihood of MERS-CoV during pregnancy.[@bib2], [@bib3], [@bib4], [@bib5], [@bib6], [@bib7] We searched the MEDLINE database for articles published in English literature from January 2012 to July 2016. The references in the retrieved articles were further searched for any additional references. A summary of previous reports and the current two additional cases of pregnancy associated MERS-CoV is presented in [Table 1](#tbl1){ref-type="table"} . Of all the cases, the mean age ± SD was 33.7 ± 4.3 years and the gestation age was 26.3 ± 9 weeks, and there were four (36%) primi-gravida. The source of infection was not identified in 3 cases; contact with family members who had MERS-CoV was elucidated in two cases; four patients had health-care associated infection, two of them were healthcare workers. Six (54%) patients required ICU admission and three (27%) patients died during the hospital stay. Two of the deceased had an exposure during the third trimester and one acquired the infection during the second trimester. The infant death rate was 27%. The outcome was favorable in the majority of pregnancy-associated MERS-CoV cases. The exact prevalence of MERS-CoV antibodies and exposure of pregnant women to MERS-CoV is not known. All the reported cases were symptomatic. Among the 11 pregnancy-associated MERS-CoV infection, the case fatality rate was not statistically different when compared to the overall case fatality rate of 35%, P = 0.75. Regarding the infants, three (27%) infants had died.Table 1A summary of pregnancy associated MERS-CoV infection.Table 1AgeNationalityGravida (G), Para (P)Source of infectionGestational age at illness onset (weeks)ICU admissionMaternal comorbid conditionsMaternal outcomeFetal outcomeDelivery detailsReferencePatient 1 (PMAH)29SaudiG2, P1Household contact6NONoneSurvivedSurvivedDelivery at termCurrent reportPatient 2 (PMAH)39SaudiG6, P5Contact with MERS-CoV case in HD24NOESRD on hemodialysis, HTNSurvivedSurvivedDelivery at termCurrent reportPatient 334SaudiG7, P6Unknown34YESPreeclampsiaSurvivedDiedIntrauterine Fetal death at 34 weeks[@bib3]Patient 432SaudiG2, P1Unknown38YESNoneDiedSurvivedVaginal delivery at 38 weeks[@bib3]Patient 531SaudiPrimigravidaHCW, occupational exposure24YESAsthma, pulmonary fibrosisDiedDiedCaesarean section at 24 weeks[@bib3]Patient 627SaudiPrimigravidaUnknown22YESNoneSurvivedSurvivedFull term delivery[@bib3]Patient 730SaudiPrimigravidaHCW, occupational exposure23YESNoneSurvivedSurvivedFull term delivery[@bib3]Patient 839JordanianG7, P6Household contact20NONoneSurvivedStill birthStill birth at 5 months[@bib6]Patient 932United Arab EmiratesG3, P2Visited camel barn32YESNoneDiedSurvivedCaesarean section at 32 weeks[@bib5]Patient 1039South KoreanG2, P1Contact with MERS-CoV Patient in hospital35 weeks and 4 daysNOGestational DiabetesSurvivedSurvivedCaesarean section at 39 weeks[@bib2], [@bib7]Patient 1133SaudiPrimigravidaContact with MERS-CoV Patient31YesHypothyroidism and primary infertilitySurvivedSurvivedCaesarean section at 32 weeks[@bib4]

The overall case fatality rate remains high and is comparable to the overall case fatality rates. The disease had also resulted in fetal demise in 27% of cases.
